CYTH

Cyclo Therapeutics, Inc. Common Stock
CYTH

Overview Fund Activity
Delisted

CYTH was delisted on the 25th of March, 2025.

Back to rankings

23 hedge funds and large institutions have $2.1M invested in Cyclo Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
23
Holders Change
+6
Holders Change %
+35.29%
% of All Funds
0.34%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
9
Increased
8
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FFVM
1
Founders Fund V Management
California
$764K
2
FFVM
2
Founders Fund VI Management
California
$175K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$565K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$242K
5
BlackRock
5
BlackRock
New York
$77K

Top Sellers

1
VF
1
Virtu Financial
New York
$0
2
XT
2
XTX Topco
Cayman Islands
$17K
3
TRCT
3
Tower Research Capital (TRC)
New York
$9.34K
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$29
5
UBS Group
5
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$0 113 +113 New
Simplex Trading
27
Simplex Trading
Illinois
$0 200 +200 New
1
2